- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Patent holdings for IPC class A61K 47/26
Total number of patents in this class: 10386
10-year publication summary
|
747
|
763
|
883
|
924
|
1084
|
1030
|
1017
|
1068
|
1028
|
219
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4563 |
99 |
| Amgen Inc. | 4318 |
82 |
| Azurity Pharmaceuticals, Inc. | 237 |
71 |
| Takeda Pharmaceutical Company Limited | 2722 |
70 |
| Genentech, Inc. | 4058 |
62 |
| Novartis AG | 10463 |
61 |
| Allergan, Inc. | 2259 |
55 |
| Merck Sharp & Dohme LLC | 3719 |
49 |
| Pfizer Inc. | 3377 |
47 |
| Chiesi Farmaceutici S.p.A. | 961 |
46 |
| Hoffmann-La Roche Inc. | 3640 |
43 |
| Janssen Biotech, Inc. | 1652 |
42 |
| Daiichi Sankyo Company, Limited | 1880 |
41 |
| Alkermes Pharma Ireland Limited | 256 |
40 |
| Chugai Seiyaku Kabushiki Kaisha | 1395 |
40 |
| Astellas Pharma Inc. | 1049 |
38 |
| Hanmi Pharm. Co., Ltd. | 591 |
38 |
| F. Hoffmann-La Roche AG | 7882 |
35 |
| Bristol-myers Squibb Company | 4793 |
32 |
| Arecor Limited | 104 |
30 |
| Other owners | 9365 |